£266.99

Advances in Medicine and Biology. Volume 129

Price data last checked 36 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£267 today · previous high £267 · all-time low £215

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical
Generating forecast…
£266.99 £209.80 £222.28 £234.76 £247.23 £259.71 £272.19 14 April 2026 27 April 2026 11 May 2026 24 May 2026 07 June 2026

Price Distribution

Price distribution over 55 days • 2 price levels

Days at Price
Current Price
50 days 5 days · current 0 13 25 38 50 £215 £267 Days at Price

Price Analysis

Most common price: £215 (50 days, 90.9%)

Price range: £215 - £267

Price levels: 2 different prices over 55 days

Description

In this collection, the authors review novel findings strongly suggesting that YS110, a humanized monoclonal antibody with high affinity to the CD26 antigen, represents a promising novel therapy for refractory cancers, immune disorders and MERS-CoV infection. This book show that in vivo administration of YS110 inhibits tumor cell growth, migration and invasion, and enhances survival of mouse xenograft models inoculated with malignant mesothelioma (MPM), renal cell carcinoma, non-small-cell lung carcinoma, ovarian carcinoma or T-cell lymphoma via multiple mechanisms of action. Afterwards, several of the antibacterial resistance mechanisms employed by bacteria are discussed, especially those that can be targeted by novel antibacterial agents to combat resistant organisms. These mechanisms include alterations of cell wall or cell wall metabolites, mutations in antibiotic target, antibiotic deactivation by bacterial enzymes and biofilm formation. Later, the authors introduce AdRx as a treatment modality in musculo-skeletal pain, explain its rationale and techniques offering indications and contraindications for its usage. While AdRx takes its original theory from Eunice Inghams teaching and from followers of her teachings, this chapter confines the content to AdRx as standalone therapy in the context of musculo-skeletal pain. Near-infrared spectroscopy (NIRS) is also introduced as a non-invasive monitoring method that allows continuous real-time monitoring of cerebral hemoglobin oxygen saturation in a small area of the frontal cortex. This monitoring tool is based on the principle that some biological materials are relatively permeable to near-infrared light. In a separate study, trans-synaptic tracing from the visually responsive sites in the superior colliculus to the retina were studied using attenuated pseudorabies virus. The results demonstrated the presence of synaptic connections between the transplant and the host retina that contribute to the visual improvement observed in the superior colliculus. Continuing, in 2015, a novel pathogenesis of Crohns disease (the Hruska Postulate) was published. The authors aim to take what is known about Mycobacterium avium subspecies paratuberculosis, Crohns disease, and the Hruska Postulate and determine why Crohns disease is potentially curable. Several researchers have been trying to identify biomarkers that can be used for Crohns disease in clinical practice, however, further studies are required in order to validate most of their findings. The closing chapter introduces several diagnostic imaging techniques for kidney stone detection. A new imaging technique of C-arm tomosynthesis is described to generate volumetric information of the kidney to identify the size and location of kidney stones with limited amount of radiation dose.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
01 April 2018
Listed Since
14 May 2018

Barcode

No barcode data available

Similar Products You Might Like

Tumor Immunology (Advances in Immunology): Volume 130
77% match

Tumor Immunology (Advances in Immunology): Volume 130

Academic Press

£117.00 22 Jun 2026
Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
76% match

Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)

Springer

£107.63 24 May 2026
Bridging the Gap: In This Era of Cancer Immunotherapy (Cancer Etiology, Diagnosis and Treatments)
75% match

Bridging the Gap: In This Era of Cancer Immunotherapy (Cancer Etiology, Diagnosis and Treatments)

£203.99 09 Jun 2026
Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)
75% match

Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer: 17 (AAPS Advances in the Pharmaceutical Sciences Series, 17)

Springer

£83.82 02 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
75% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B: Volume 166 (Advances in Immunology, Volume 166)
74% match

Advances in DNA and mRNA-Based strategies for Cancer Immunotherapy: Part B: Volume 166 (Advances in Immunology, Volume 166)

Academic Press

£119.23 31 May 2026
Advancements and Innovations in Health Sciences: 1211 (Advances in Experimental Medicine and Biology, 1211)
74% match

Advancements and Innovations in Health Sciences: 1211 (Advances in Experimental Medicine and Biology, 1211)

Springer

£103.44 06 Jun 2026
Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology, 207)
74% match

Recombinant Antibodies for Cancer Therapy: Methods and Protocols: 207 (Methods in Molecular Biology, 207)

Humana

£81.58 26 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
74% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science
74% match

Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science

Springer

£107.98 01 Jun 2026
Advances in Medicine and Biology: Volume 131
74% match

Advances in Medicine and Biology: Volume 131

£266.99 07 Jun 2026
74% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 22 May 2026
Bacterial Therapy of Cancer: Methods and Protocols: 1409 (Methods in Molecular Biology, 1409)
74% match

Bacterial Therapy of Cancer: Methods and Protocols: 1409 (Methods in Molecular Biology, 1409)

Humana

£73.10 27 May 2026
Advances in Medicine & Biology: Volume 39 (Advances in Medicine & Biology Series)
73% match

Advances in Medicine & Biology: Volume 39 (Advances in Medicine & Biology Series)

£114.68 18 May 2026
Advances in Medicine & Biology: Volume 30 (Advances in Medicine & Biology Series)
73% match

Advances in Medicine & Biology: Volume 30 (Advances in Medicine & Biology Series)

£147.58 25 May 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
73% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 25 May 2026
New Advances on Disease Biomarkers and Molecular Targets in Biomedicine
73% match

New Advances on Disease Biomarkers and Molecular Targets in Biomedicine

Humana

£88.17 16 Jun 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
73% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£142.76 19 May 2026
Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)
73% match

Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)

Springer

£77.58 03 Jun 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
73% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.39 26 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
73% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 29 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
73% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.40 28 May 2026
Inflammation, Aging and Cancer: Biological Injustices to Molecular Village of Immunity that Guard Health
73% match

Inflammation, Aging and Cancer: Biological Injustices to Molecular Village of Immunity that Guard Health

Springer

£109.14 01 Jul 2026
Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment: Proceedings of the Fifth International Workshop on Breast Cancer ... in Experimental Medicine and Biology)
73% match

Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment: Proceedings of the Fifth International Workshop on Breast Cancer ... in Experimental Medicine and Biology)

Springer

£79.08 20 May 2026